EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents

Qingqing Fan, Yujiao Guo, Xiang Hui, Yu Zhang, Jianrui Li, Jinhua Liang, Yongqing Wang iD

Current Oncology · 13.06.2026 · 33 (6) · 357

DOI: 10.3390/curroncol33060357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 13.06.2026. Verfasst von Qingqing Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Nomograms, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Sulfonamides. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Hospital Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the predictive factors for resistance to VEN combined with HMAs in the treatment of AML, construct a drug resistance prediction model, and visualize the model. A retrospective analysis was conducted on 74 AML patients. Multivariate logistic regression was used to identify independent predictors of primary resistance, based on which a nomogram model and a risk scoring system for drug resistance were constructed. The results showed that KIT (p = 0.012), TP53 (p = 0.010), and FAB-M5 (p = 0.059) were significantly associated with primary resistance to VEN. A nomogram prediction model incorporating FAB-M5, KIT, and TP53 was established. Based on the nomogram model, a drug resistance prediction scoring tool comprising three variables was developed, categorizing patients into high-risk (6–10 points), intermediate-risk (3–5 points), and low-risk (0–2 points) groups. Significant differences in NR rates were observed among the three risk groups (p < 0.001). KIT, TP53, and FAB-M5 are independent factors influencing VEN resistance. The constructed nomogram prediction model and scoring system may provide valuable references for predicting primary resistance to VEN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsBridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcuteSulfonamidesDrug Resistance, NeoplasmHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultPrediction Algorithms

Stichwörter der Autor:innen

BCL2acute myeloid leukemiadrug resistanceprediction modelvenetoclax

Substanzen

Bridged Bicyclo Compounds, HeterocyclicvenetoclaxSulfonamides

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.

ORCID-Profile: Yongqing Wang

Förderung

  • Jiangsu Provincial Hospital Association

Zitieren

APA

Fan, Q., Guo, Y., Hui, X., Zhang, Y., Li, J., Liang, J., & Wang, Y. (2026). A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents. Current Oncology, 33(6), 357. https://doi.org/10.3390/curroncol33060357

Vancouver

Fan Q, Guo Y, Hui X, Zhang Y, Li J, Liang J, et al. A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents. Current Oncology. 2026;33(6):357. doi:10.3390/curroncol33060357

BibTeX
@article{Fan2026,
  author = {Fan, Qingqing and Guo, Yujiao and Hui, Xiang and Zhang, Yu and Li, Jianrui and Liang, Jinhua and Wang, Yongqing},
  title = {A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {357},
  doi = {10.3390/curroncol33060357}
}
Kostenlos starten →